Skip to main content
Clinical Trials/ISRCTN13704894
ISRCTN13704894Completed未知

Pharmacogenetics to avoid loss of hearing (clinical implementation study)

Manchester University NHS Foundation Trust0 sites900 target enrollmentStarted: April 25, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
900

Study Overview

Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34135034/ (added 18/06/2021) 2022 Results article in https://jamanetwork.com/journals/jamapediatrics/fullarticle/2790066 (added 08/06/2022) 2024 Results article in https://doi.org/10.1111/jan.16045 qualitative study (added 08/01/2024)

Study Design

Study Type
Observational

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. All babies admitted to NICU at Manchester University NHS Foundation Trust (MFT, Oxford Road Campus) and Liverpool Women's NHS Foundation Trust (LWH), for 6 months commencing from the trial start date
  • 2. Babies requiring a screen for infection within 72 hours of birth (an infection screen for suspected early onset neonatal infection) at LWH who are not formally admitted to the neonatal unit, for 6 months commencing from the trial start date

Exclusion Criteria

  • Neonates requiring antibiotics immediately with already established IV access

Investigators

Similar Trials